Plugging (publicising) to prevent mucous plugging

European Respiratory Journal

Volumn 36, Issue 6, 2010, Pages 1236-1238

  Burgel, P R ^a   Nadel, J A ^b,c  

^a Université Paris Descartes ^*  (France)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; I KAPPA B; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; MUCIN; MUCIN 5AC; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR;

AIRWAY; ASTHMA; BRONCHOSCOPY; CELL INTERACTION; CELL SURVIVAL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CILIATED EPITHELIUM; CYSTIC FIBROSIS; DISEASE EXACERBATION; EDITORIAL; ENZYME ACTIVATION; EPITHELIUM CELL; MUCUS SECRETION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; RADIODIAGNOSIS; RHINOVIRUS; SIGNAL TRANSDUCTION;

HUMANS; LUNG DISEASES, OBSTRUCTIVE; MUCUS;

EID: 78649756981     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00100610     Document Type: Editorial

References (13)

1. Nadel JA. Airway epithelial mucins and mucous hypersecretion. In: Murray JF, Nadel JA, eds. Textbook of Respiratory Medicine. 5th Edn. Philadelphia, Elsevier, 2010; pp. 226-235.
2. King M, Rubin BK. Pharmacological approaches to discovery and development of new mucolytic agents. Adv Drug Deliv Rev 2002; 54: 1475-1490.
3. Curran DR, Cohn L. Advances in mucous cell metaplasia: a plug for mucus as a therapeutic focus in chronic airway disease. Am J Respir Cell Mol Biol 2010; 42: 268-275.
4. O'Riordan T, Smaldone GC. Aerosol deposition and clearance. In: Murray JF, Nadel JA, eds. Textbook of Respiratory Medicine. 5th Edn. Philadelphia, Elsevier, 2010; pp. 236-254.
5. Cardell BS, Pearson RSB. Death in asthmatics. Thorax 1959; 14: 341-352.
6. Aikawa T, Shimura S, Sasaki H, et al. Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack. Chest 1992; 101: 916-921.
7. Shimura S, Andoh Y, Haraguchi M, et al. Continuity of airway goblet cells and intraluminal mucus in the airways of patients with bronchial asthma. Eur Respir J 1996; 9: 1395-1401.
8. Groneberg DA, Eynott PR, Lim S, et al. Expression of respiratory mucins in fatal status asthmaticus and mild asthma. Histopathology 2002; 40: 367-373.
9. Takeyama K, Dabbagh K, Lee HM, et al. Epidermal growth factor system regulates mucin production in airways. Proc Natl Acad Sci USA 1999; 96: 3081-3086.
10. Burgel PR, Nadel JA. Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases. Eur Respir J 2008; 32: 1068-1081.
11. Zhu L, Lee PK, Lee WM, et al. Rhinovirus-induced major airway mucin production involves a novel TLR3-EGFR-dependent pathway. Am J Respir Cell Mol Biol 2009; 40: 610-619.
12. Bartlett NW, Walton RP, Edwards MR, et al. Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation. Nat Med 2008; 14: 199-204.
13. Hewson CA, Haas JJ, Bartlett NW, et al. Rhinovirus induces MUC5AC in a human infection model and in vitro via NF-κB and EGFR pathways. Eur Respir J 2010; 36: 1425-1435.